CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows used in operating activities
Net loss	$ (23,870,546)	$ (12,850,301)
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation	596,505	474,621
Amortization	385,093	10,152
Gain on disposal of equipment	(6,400)	0
Stock-based compensation	4,040,207	2,318,502
Reserve for prepaid assets	179,000	0
Restricted stock awards	0	62,431
Noncash conversion of note payable to grant income	(51,000)	0
Impairment on property, plant, and equipment	8,317	239,734
Deferred taxes	7,534	0
Gain on sale of investment securities available-for-sale	0	13,927
Changes in operating assets and liabilities:
Accounts receivable	(382,970)	(454,853)
Inventory	(3,199,439)	(3,859,932)
Prepaid expenses and other current assets	(922,058)	(2,256,511)
Deferred rent	368,894	360,786
Deposits	(86,920)	30,954
Accounts payable	(474,519)	591,213
Payroll liabilities	82,059	231,824
Accrued expenses	1,230,436	403,481
Net cash from operating activities	(22,095,807)	(14,683,972)
Cash flows used in investing activities
Purchase of property, plant, and equipment	(1,555,191)	(1,059,858)
Proceeds on sale of property, plant, and equipment	12,700	0
Deposits on equipment to be acquired	(489,325)	0
Purchase of software	(156,855)	0
Acquisition of a business, net of cash acquired (note 2)	(10,449,587)	0
Purchase of investment securities available-for-sale	(1,028)	(8,171,129)
Proceeds from maturities of investment securities available-for-sale	0	4,950,000
Net cash from investing activities	(12,639,286)	(4,280,987)
Cash flows from financing activities
Issuance of common stock	66,744	66,110,517
Issuance of preferred stock	0	10,000,006
Common stock issuance costs	(82,043)	(1,268,772)
Preferred stock issuance costs	0	(147,721)
Capital contribution	0	298,103
Restricted stock units issued	48	0
Withholding tax payments for share based compensation	(219,158)	0
Repurchased common stock	0	(20,532)
Stock options exercised	810,656	197,329
Net cash from financing activities	576,247	75,168,930
Net change in cash and cash equivalents	(34,158,846)	56,203,971
Cash and cash equivalents beginning of period	57,208,080	1,004,109
Cash and cash equivalents end of period	23,049,234	57,208,080
Supplemental disclosures of non-cash information
Noncash conversion of note payable to grant income	51,000	0
Unrealized gain (loss) on available-for-sale securities	(75,223)	14,433
Common stock issued in connection with the acquistion of a business (note 2)	1,834,857	0
Conversion of preferred stock to common stock	0	16,575,236
Purchases of equipment included in deposits at the beginning of the period	0	14,699
Purchases of equipment included in accrued expenses	$ 26,141	$ 0